whatshot

AYLA   $0.5036  12.90% Market Closed

Ayala Pharmaceuticals Inc
show_chart Advanced Chart of AYLA
Last Events:

2023-03-29 Trend pattern changed from нисходящий клин to расходящийся клин с наклоном вниз.

2023-03-29 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

2023-03-29 Signal in RSI changed from bullish to bearish weakening. RSI indicator is in the lower part of the neutral territory and it heading north. These factors indicate that the upside trend is forming Last signal: entrance to the overbought zone.

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вниз to нисходящий клин.

2023-03-29 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in overbought territory and it grows. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: entrance to the overbought zone.

2023-03-29 Signal in RSI changed from bearish weakening to bullish. RSI indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: entrance to the overbought zone.

2023-03-28 Trend pattern changed from нисходящий клин to расходящийся клин с наклоном вниз.

2023-03-28 Signal in Stochastic changed from bullish to bearish. The stochastic indicator is in the lower part of the neutral territory and it falls. These factors indicate that negative dynamics persists. Last signal: down-crossing the middle level.

Current temperature: 2.19
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.45
Target: 12.00
High with 47% probability: 2.54
Analyst Recommendations:
Number of estimates 1
Target Price Mean 12.00
Mean unverified/preliminary 12.00 / 12.00
Target Price Low / High 12.00 / 12.00
Median / STD DEV 12.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd Sell Sell -
stoch Sell Sell Sell
ma20 - - -
ma50 - Sell -
ma100 Sell - -
Candlestick PatternJan. 10, 2023 Bearish Harami - consists of an unusually large white body followed by a small black body contained within. Large white body It is considered as a bearish pattern when preceded by an uptrend.
ISIN US05465V1089
ceo Dr. Roni Mamluk M.D., Ph.D.
Website https://www.ayalapharma.com
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinical trial for the treatment of recurrent/metastatic adenoid cystic carcinoma for patients bearing Notch-activating mutations. It is also involved in developing AL102, a potent, selective, and oral small molecule GSI that is in Phase II/III pivotal study for the treatment of desmoid tumors. Ayala Pharmaceuticals, Inc. has a collaboration agreement with Novartis International Pharmaceutical Limited to develop AL102 for the treatment of multiple myeloma. The company was incorporated in 2017 and is headquartered in Rehovot, Israel.